Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +44.70%
#3 CoW Protocol CoW Protocol +38.40%
#4 Enso Enso +21.62%
#5 Tutorial Tutorial +21.15%
#6 Codatta Codatta +21.08%
#7 Humanity Humanity +19.46%
#8 Walrus Walrus +19.26%
#9 BOOK OF MEME BOOK OF MEME +17.59%
#10 Ribbita by Virtuals Ribbita by Virtuals +12.58%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Cellular Goods PLC Cellular Goods PLC

Cellular Goods PLC

CBX
Rank in Stocks #36861
Cellular Goods PLC, along with its associated companies, specializes in... Cellular Goods PLC, along with its associated companies, specializes in creating and distributing consumer products infused with biosynthetic cannabinoids throughout the United Kingdom. Their portfolio includes cannabinoid-based solutions designed for both skincare applications and oral consumption. These items are available for purchase via traditional retailers, directly to customers through their proprietary website, and across various online platforms. Established in 2018, the organization was originally named Leaf Studios PLC, subsequently adopting the Cellular Goods PLC moniker in September 2020, and maintains its headquarters in London, UK.
Share Price
$0.00447785
Last synced: 2024-03-12
Market Cap
$2.26M
Change (1 day)
7.54%
Change (1 year)
0.00%
Country
GB
Trade Cellular Goods PLC (CBX)

Category

Healthcare
Number of shares outstanding for Cellular Goods PLC (CBX)
Number of shares outstanding as of August 2026: 0
According to Cellular Goods PLC latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cellular Goods PLC (CBX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 445.06M -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 105.38M -
US